Data / Form D filings / Adimab, LLC
Adimab, LLC: Form D filing
Adimab, LLC, a biotechnology company in Lebanon, NH, filed a Form D with the SEC in 2012. The latest, on April 2, 2012, reports $13.8 million sold of a $13.8 million offering to 12 investors.
Find out what Adimab, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7 LUCENT DRIVE, Lebanon, NH, 03766
- Phone
- (603) 643-7110
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1545672
The full lists. Form D filings in New Hampshire: 127 rows, $6.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2012 | New notice | $13,816,447 | $13,816,447 | $0 | 12 | Mar 16, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fran J. Heller | Director | |
| Tillman U. Gerngross | Executive Officer, Director | |
| Errik B. Anderson | Executive Officer, Director | |
| Michael J. Ross | Director | |
| Robert L. Birnbaum | Executive Officer | |
| Terrance L. McGuire | Director | |
| William J. Maris | Director |
Every Form D from the week of Apr 2, 2012 · All recent filings in New Hampshire · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adimab, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.